Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -0.41% vs 9.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 45.27% vs -42.42% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 15.59% vs -16.24% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -18.18% vs 2.67% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.66% vs 3.06% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -0.41% vs 9.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -27.79% vs 655.24% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 45.27% vs -42.42% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -15.98% vs 64.81% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 15.59% vs -16.24% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -4.91% vs -27.60% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -18.18% vs 2.67% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






